Dose-finding study of the checkpoint kinase 1 inhibitor, prexasertib, in Japanese patients with advanced solid tumors.
Iwasa S, Yamamoto N, Shitara K, Tamura K, Matsubara N, Tajimi M, Lin AB, Asou H, Cai Z, Inoue K, Shibasaki Y, Saito K, Takai H, Doi T.
Iwasa S, et al. Among authors: cai z.
Cancer Sci. 2018 Oct;109(10):3216-3223. doi: 10.1111/cas.13750.
Cancer Sci. 2018.
PMID: 30040168
Free PMC article.
Clinical Trial.